Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CStone Pharmaceuticals Director's Dealing 2022

Jul 25, 2022

50715_rns_2022-07-25_1c3ac18c-f781-497a-8072-35baa8d4a06e.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [173 x 58] intentionally omitted <==

Public Disclosure Form

25 July 2022

Possible offer

Disclosure of dealings in the shares of Yankuang Energy Group Company Limited

The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:

Party Date Description
of relevant
securities
Nature of dealings Purchase /
Sale
Total
number
of
shares
involved
Total amount
paid / received
Highest (H)
prices paid
/ received
Lowest (L)
prices paid
/ received
China
International
Capital
Corporation
Limited
22 July
2022
Ordinary
shares
Hedging as a result of the creation of
new index-tracking ETFs where the
relevant securities represent less than
1% of the class in issue and less than
20% of the value of the securities in the
basket or index
Purchase 21,500 $776,289.0000 $36.2062 $35.8200

End

Public Disclosure Form

==> picture [71 x 43] intentionally omitted <==

Note:

China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.

The shares reported refer to A shares of Yankuang Energy Group Company Limited (600188.SH), and price per unit is in RMB.